TGFBR2 and asthma: Other research described a novel regulatory pathway involving miR-19a, which is critical to the severe asthma phenotype, in which down-regulation of miR-19a expression could be explored as a potential new therapy to modulate epithelial repair in asthma by targeting the TGFβR2 gene [51].